Latest Stock Market News

This can indicate potential upward movement and may be used by traders to identify buying opportunities.

NATCO Pharma share price opened sharply lower on Thursday after the company reported a 37.75% YoY decline in net profit to Rs 132.4 crore for Q3FY25. Formulation exports fell significantly, while API revenue showed growth. Despite the drop in profits, the company declared a third interim dividend of Rs 1.50 per share. The stock has a target price of Rs 1,349.

Indian stock markets are experiencing significant declines, with over 400 large-cap stocks dropping at least 20% from their peak. Influenced by factors like FII withdrawal and economic concerns, investors are urged to consider reassessing their portfolios. Analysts recommend leveraging the downturn to invest in fairly valued large-cap stocks for potential long-term gains.

Indian benchmark indices, Sensex and Nifty, opened higher on Thursday after snapping a six-day losing streak. Gains in banking and financial stocks led the upswing, bolstered by domestic inflation data suggesting a potential rate cut. Notable gainers included Kotak Bank and Sun Pharma, while IT stocks lagged due to rising US consumer inflation.

Axis Securities has a buy call on CCL Products India with a target price of Rs 730. The firm is enjoying consistent gains despite volatile coffee prices, supported by facilities in Vietnam and India, cost-efficient operations, rapid capacity expansion, and growing domestic brand presence. Promoters hold a 46.09% stake, while FIIs have 10.13%.

On February 12, five NSE stocks with a market cap over Rs 1000 crore showed a "White Marubozu" bullish pattern, signaling strong buying pressure. This candlestick pattern suggests potential upward momentum in these stocks.

The Indian stock market is experiencing a correction phase with significant variations in damage across sectors. Analysts recommend a focus on long-term investment, avoiding panic selling and speculative stocks while diversifying portfolios. Defensive strategies and disciplined approach are crucial amid ongoing market volatility.

Federal Reserve Chairman Jerome Powell stated that the process of reducing the central bank s balance sheet, known as quantitative tightening (QT), is still ongoing. Despite some banks anticipating an end in June, revised estimates suggest QT may continue through the third quarter of this year.

Cholamandalam Investment s Arul Selvan highlights a target of 20%-25% AUM growth, noting past peaks like 40% post-COVID due to expansion in LAP and home loans. Selvan explains growth variability across sectors, focusing on steady AUM for sustained interest income. He anticipates moderate reductions in NPAs by Q4 FY26, with pressure seen in vehicle finance.